InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the full record of transactions filed by Walts Alan Edmund, 董事. Director active across 1 company, notably Eloxx Pharmaceuticals, Inc.. In total, 3 disclosures have been recorded. Activity tracked since 1 December 2021. The latest transaction was disclosed on 24 January 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Walts Alan Edmund
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
3,750 股0Common StockSEC:0001104659-25-006781:0
12,000 股0Common StockSEC:0001104659-24-109525:0
37,695 股0Common StockSEC:0001415889-21-005694:0
3 条申报中的 3 条
About Walts Alan Edmund
Alan Edmund Walts serves as a Director of Eloxx Pharmaceuticals, Inc. As a board member, he contributes to overseeing the company's operations and making strategic decisions. Alan brings expertise in the pharmaceutical sector, which is crucial for the growth and innovation of Eloxx. His commitment to corporate governance is essential for ensuring transparency and accountability.
